Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment.
Osborne N, Sundseth R, Burks J, Cao H, Liu X, Kroemer AH, Sutton L, Cato A, Smith JP.
Cancer Immunol Immunother. 2019 Oct;68(10):1635-1648. doi: 10.1007/s00262-019-02398-6. Epub 2019 Sep 24.
The Role of Gastrin and CCK Receptors in Pancreatic Cancer and other Malignancies.
Smith JP, Fonkoua LK, Moody TW.
Int J Biol Sci. 2016 Jan 28;12(3):283-91. doi: 10.7150/ijbs.14952. eCollection 2016.
Endogenous Gastrin Collaborates With Mutant KRAS in Pancreatic Carcinogenesis.
Nadella S, Burks J, Huber M, Wang J, Cao H, Kallakury B, Tucker RD, Boca SM, Jermusyck A, Collins I, Vietsch EE, Pierobon M, Hodge KA, Cui W, Amundadottir LT, Petricoin E 3rd, Shivapurkar N, Smith JP.
Pancreas. 2019 Aug;48(7):894-903. doi: 10.1097/MPA.0000000000001360.
Gastrin.
Sanders MG, Schimmel EM.
Am J Med. 1970 Sep;49(3):380-94. doi: 10.1016/s0002-9343(70)80030-4.
What are the pancreatic target cells for gastrin and its CCKB receptor? Is this a couple for cancerous cells?
Morisset J, Lainé J, Biernat M, Julien S.
Med Sci Monit. 2004 Oct;10(10):RA242-6. Epub 2004 Sep 23.
Gastrinoma--morphological aspects.
Klöppel G, Anlauf M.
Wien Klin Wochenschr. 2007;119(19-20):579-84. doi: 10.1007/s00508-007-0885-1.
Endocrine pancreatic tumors.
Larsson LI.
Hum Pathol. 1978 Jul;9(4):401-16. doi: 10.1016/s0046-8177(78)80026-4.
Reflections on some pilot trials of gastrin receptor blockade in pancreatic cancer.
Black JW.
Eur J Cancer. 2009 Feb;45(3):360-4. doi: 10.1016/j.ejca.2008.11.026. Epub 2009 Jan 7.
Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes.
Zeng Q, Ou L, Wang W, Guo DY.
Front Endocrinol (Lausanne). 2020 Mar 6;11:112. doi: 10.3389/fendo.2020.00112. eCollection 2020.
Gastrin receptor pharmacology.
Dockray GJ, Moore A, Varro A, Pritchard DM.
Curr Gastroenterol Rep. 2012 Dec;14(6):453-9. doi: 10.1007/s11894-012-0293-1.
